Guidance for Industry: Recommendations for the Assessment of Donor Suitability and Blood Product Safety in Cases of Suspected Severe Acute Respiratory Syndrome (SARS) or Exposure to SARS
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 17, 2003
June 15, 2019
c0e0abf6-5a1e-422e-a51d-6fce1784f489
Related Documents
Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy: Guidance for Industry
Guidance DocumentAugust 1, 2016Center for Biologics Evaluation and Research
Recommendations for Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Possible Exposure to Anthrax: Guidance for Industry
Guidance DocumentOctober 17, 2001Center for Biologics Evaluation and Research
Biological Product Deviation Reporting for Blood and Plasma Establishments: Guidance for Industry
Guidance DocumentMarch 12, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.